A 9-centimorgan interval of chromosome 10 controls the T cell-dependent psoriasiform skin disease and arthritis in a murine psoriasis model

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5520-5529

  Wang, Honglin ^a   Kess, Daniel ^a   Lindqvist, Anna Karin B ^b   Peters, Thorsten ^a   Sindrilaru, Anca ^a   Wlaschek, Meinhard ^a   Blakytny, Robert ^a   Holmdahl, Rikard ^b   Scharffetter Kochanek, Karin ^a  

^a UNIVERSITY OF ULM   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CHROMOSOME 10; CONTROLLED STUDY; DISEASE RESISTANCE; FEMALE; GENE LOCUS; GENOME; LINKAGE ANALYSIS; LYMPHOCYTE DEPLETION; MACROPHAGE; MALE; MOUSE; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE; ALLELE; ANIMAL; CONGENIC STRAIN; CYTOLOGY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM;

ALLELES; ANIMALS; ANTIGENS, CD18; ARTHRITIS; CD4-POSITIVE T-LYMPHOCYTES; CHROMOSOMES, HUMAN, PAIR 10; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, CONGENIC; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45949098797     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5520     Document Type: Article

References (57)

1. Schon, M. P., and W. H. Boehncke. 2005. Psoriasis. N. Engl. J. M Ed. 352: 1899-1912.
2. Nickoloff, B. J., and F. O. Nestle. 2004. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 113: 1664-1675.
3. Ritchlin, C. T., S. A. Haas-Smith, P. Li, D. G. Hicks, and E. M. Schwarz. 2003. Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111: 821-831.
4. Rahman, P., and J. T. Elder. 2005. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann. Rheum. Dis. 64 (Suppl. 2) : ii37-ii39; discussion ii40-ii31.
5. Krueger, J. G. 2002. The immunologic basis for the treatment of psoriasis with new biologic agents. J. Am. Acad. Dermatol. 46: 1-23; quiz 23-26.
6. Prinz, J. C. 1997. Psoriasis vulgaris, streptococci and the immune system: a riddle to be solved soon? Scand. J. Immunol. 45: 583-586.
7. Valdimarsson, H., B. S. Baker, I. Jonsdottir, A. Powles, and L. Fry. 1995. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol. Today 16: 145-149.
8. Wang, H., T. Peters, D. Kess, A. Sindrilaru, T. Oreshkova, N. Van Rooijen, A. Stratis, A. C. Renkl, C. Sunderkotter, M. Wlaschek, et al. 2006. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 116: 2105-2114.
9. Clark, R. A., and T. S. Kupper. 2006. Misbehaving macrophages in the pathogenesis of psoriasis. J. Clin. Invest. 116: 2084-2087.
10. Henseler, T., and E. Christophers. 1985. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J. Am. Acad. Dermatol. 13: 450-456.
11. Nair, R. P., T. Henseler, S. Jenisch, P. Stuart, C. K. Bichakjian, W. Lenk, E. Westphal, S. W. Guo, E. Christophers, J. J. Voorhees, and J. T. Elder. 1997. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet. 6: 1349-1356.
12. Trembath, R. C., R. L. Clough, J. L. Rosbotham, A. B. Jones, R. D. Camp, A. Frodsham, J. Browne, R. Barber, J. Terwilliger, G. M. Lathrop, and J. N. Barker. 1997. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum. Mol. Genet. 6: 813-820.
13. Tomfohrde, J., A. Silverman, R. Barnes, M. A. Fernandez-Vina, M. Young, D. Lory, L. Morris, K. D. Wuepper, P. Stastny, A. Menter, et al. 1994. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264: 1141-1145.
14. Matthews, D., L. Fry, A. Powles, J. Weber, M. McCarthy, E. Fisher, K. Davies, and R. Williamson. 1996. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat. Genet. 14: 231-233.
15. Zhang, X. J., P. P. He, Z. X. Wang, J. Zhang, Y. B. Li, H. Y. Wang, S. C. Wei, S. Y. Chen, S. J. Xu, L. Jin, et al. 2002. Evidence for a major psoriasis susceptibility locus at 6p21 (PSORS1) and a novel candidate region at 4q31 by genomewide scan in Chinese Hans. J. Invest. Dermatol. 119: 1361-1366.
16. Capon, F., G. Novelli, S. Semprini, M. Clementi, M. Nudo, P. Vultaggio, C. Mazzanti, T. Gobello, A. Botta, G. Fabrizi, and B. Dallapiccola. 1999. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J. Invest. Dermatol. 112: 32-35.
17. Enlund, F., L. Samuelsson, C. Enerback, A. Inerot, J. Wahlstrom, M. Yhr, A. Torinsson, J. Riley, G. Swanbeck, and T. Martinsson. 1999. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur. J. Hum. Genet. 7: 783-790.
18. Veal, C. D., R. L. Clough, R. C. Barber, S. Mason, D. Tillman, B. Ferry, A. B. Jones, M. Ameen, N. Balendran, S. H. Powis, et al. 2001. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J. Med. Genet. 38: 7-13.
19. Bowcock, A. M., and J. N. Barker. 2003. Genetics of psoriasis: the potential impact on new therapies. J. Am. Acad. Dermatol. 49: S51-S56.
20. Sundberg, J. P., R. W. Dunstan, D. R. Roop, and W. G. Beamer. 1994. Fullthickness skin grafts from flaky skin mice to nude mice: maintenance of the psoriasiform phenotype. J. Invest. Dermatol. 102: 781-788.
21. Hammer, R. E., S. D. Maika, J. A. Richardson, J. P. Tang, and J. D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63: 1099-1112.
22. Sano, S., K. S. Chan, S. Carbajal, J. Clifford, M. Peavey, K. Kiguchi, S. Itami, B. J. Nickoloff, and J. DiGiovanni. 2005. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. M Ed. 11: 43-49.
23. +T cells. Nat. M Ed. 3: 183-188.
24. Pasparakis, M., G. Courtois, M. Hafner, M. Schmidt-Supprian, A. Nenci, A. Toksoy, M. Krampert, M. Goebeler, R. Gillitzer, A. Israel, et al. 2002. TNF- mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417: 861-866.
25. Carroll, J. M., M. R. Romero, and F. M. Watt. 1995. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83: 957-968.
26. Boehncke, W. H., W. Sterry, A. Hainzl, W. Scheffold, and R. Kaufmann. 1994. Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice. Arch. Dermatol. Res. 286: 325-330.
27. Zenz, R., R. Eferl, L. Kenner, L. Florin, L. Hummerich, D. Mehic, H. Scheuch, P. Angel, E. Tschachler, and E. F. Wagner. 2005. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun. proteins. Nature 437: 369-375.
28. Bullard, D. C., K. Scharffetter-Kochanek, M. J. McArthur, J. G. Chosay, M. E. McBride, C. A. Montgomery, and A. L. Beaudet. 1996. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc. Natl. Acad. Sci. USA 93: 2116-2121.
29. Hynes, R. O. 1987. Integrins: a family of cell surface receptors. Cell 48: 549-554.
30. + T cells. Br. J. Dermatol. 133: 823-829.
31. Kerkhof, P. C. M., and C. M. R. Weemaes. 1990. Skin manifestations in congenital deficiency of leucocyte-adherence glycoproteins (CDLG). Br. J. Dermatol. 123: 395-401.
32. Gencik, M., S. Meller, S. Borgmann, T. Sitter, A. M. Menezes Saecker, H. Fricke, and J. T. Epplen. 2000. The association of CD18 alleles with antimyeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin. Immunol. 94: 9-12.
33. + vasculitis. Genes Immun. 2: 269-272.
34. Kess, D., A. K. Lindqvist, T. Peters, H. Wang, J. Zamek, R. Nischt, K. W. Broman, R. Blakytny, T. Krieg, R. Holmdahl, and K. Scharffetter-Kochanek. 2006. Identification of susceptibility loci for skin disease in a murine psoriasis model. J. Immunol. 177: 4612-4619.
35. Wakeland, E., L. Morel, K. Achey, M. Yui, and J. Longmate. 1997. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol. Today 18: 472-477.
36. Truett, G. E., P. Heeger, R. L. Mynatt, A. A. Truett, J. A. Walker, and M. L. Warman. 2000. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and Tris (HotSHOT). BioTechniques 29: 52-54.
37. + T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis. J. Immunol. 171: 5697-5706.
38. Jirholt, J., A. K. Lindqvist, J. Karlsson, A. Andersson, and R. Holmdahl. 2002. Identification of susceptibility genes for experimental autoimmune encephalomyelitis that overcome the effect of protective alleles at the eae2 locus. Int. Immunol. 14: 79-85.
39. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89: 9784-9788.
40. Wrone-Smith, T., and B. J. Nickoloff. 1996. Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98: 1878-1887.
41. Prinz, J. C. 2003. The role of T cells in psoriasis. J. Eur. Acad. Dermatol. Venereol. 17: 257-270.
42. Boyman, O., H. P. Hefti, C. Conrad, B. J. Nickoloff, M. Suter, and F. O. Nestle. 2004. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J. Exp. Med. 199: 731-736.
43. Bhalerao, J., and A. M. Bowcock. 1998. The genetics of psoriasis: a complex disorder of the skin and immune system. Hum. Mol. Genet. 7: 1537-1545.
44. Gladman, D. D., K. A. Anhorn, R. K. Schachter, and H. Mervart. 1986. HLA antigens in psoriatic arthritis. J. Rheumatol. 13: 586-592.
45. Eastmond, C. J. 1994. Psoriatic arthritis. Genetics and HLA antigens. Baillieres Clin. Rheumatol. 8: 263-276.
46. Gudjonsson, J. E., A. Karason, A. A. Antonsdottir, E. H. Runarsdottir, J. R. Gulcher, K. Stefansson, and H. Valdimarsson. 2002. HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features. J. Invest. Dermatol. 118: 362-365.
47. Al-Heresh, A. M., J. Proctor, S. M. Jones, J. Dixey, B. Cox, K. Welsh, and N. McHugh. 2002. Tumour necrosis factor-alpha polymorphism and the HLA- Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford) 41: 525-530.
48. Perez De Nanclares, G., J. R. Bilbao, B. Calvo, and L. Castano. 2000. Analysis of chromosome 6q in Basque families with type 1 diabetes. GEPV-N. Basque- Navarre Endocrinology and Paediatric Group. Autoimmunity 33: 33-36.
49. Jawaheer, D., M. F. Seldin, C. I. Amos, W. V. Chen, R. Shigeta, J. Monteiro, M. Kern, L. A. Criswell, S. Albani, J. L. Nelson, et al. 2001. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68: 927-936.
50. Jawaheer, D., M. F. Seldin, C. I. Amos, W. V. Chen, R. Shigeta, C. Etzel A. Damle, X. Xiao, D. Chen, R. F. Lum, et al. 2003. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48: 906-916.
51. MacKay, K., S. Eyre, A. Myerscough, A. Milicic, A. Barton, S. Laval, J. Barrett, D. Lee, S. White, S. John, et al. 2002. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46: 632-639.
52. Zhou, Q., K. Rammohan, S. Lin, N. Robinson, O. Li, X. Liu, X. F. Bai, L. Yin B. Scarberry, P. Du, et al. 2003. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc. Natl. Acad. Sci. USA 100: 15041-15046.
53. Bai, X. F., J. Q. Liu, X. Liu, Y. Guo, K. Cox, J. Wen, P. Zheng, and Y. Liu. 2000. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J. Clin. Invest. 105: 1227-1232.
54. Kelly, S. C., P. Ratajczak, M. Keller, S. M. Purcell, T. Griffin, and G. Richard. 2006. A novel GJA 1 mutation in oculo-dento-digital dysplasia with curly hair and hyperkeratosis. Eur. J. Dermatol. 16: 241-245.
55. Sugie, K., M.-S. Jeon, and H. M. Grey. 2004. Activation of naive CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling. Proc. Natl. Acad. Sci. USA 101: 14859-14864.
56. Stratis, A., M. Pasparakis, R. A. Rupec, D. Markur, K. Hartmann, K. Scharffetter-Kochanek, T. Peters, N. van Rooijen, T. Krieg, and I. Haase. 2006. Pathogenic role for skin macrophages in a mouse model of keratinocyteinduced psoriasis-like skin inflammation. J. Clin. Invest. 116: 2094-2104.
57. Antoni, C., and B. Manger. 2002. Infliximab for psoriasis and psoriatic arthritis. Clin. Exp. Rheumatol. 20: S122-S125.